$ABBV Recent News Microsoft, Amazon, Starbucks are

New Post Public Reply Private Reply Replies (0) Message Board

May 9, 2014 at 11:07 AM

$ABBV Recent News

Microsoft, Amazon, Starbucks are stocks to watch 8:46 a.m. April 25, 2014 - Sue Chang
AbbVie shares rise after earnings top forecasts 8:10 a.m. April 25, 2014 - Ben Eisen
AbbVie shares rise 2.4% premarket on earnings 8:03 a.m. April 25, 2014 - Ben Eisen
Abbvie Q1 EPS tops forecast of $0.68 8:02 a.m. April 25, 2014 - Ben Eisen
AbbVie reaffirms 2014 adj EPS range of $3 to $3.10 8:00 a.m. April 25, 2014 - Ben Eisen
AbbVie Q1 sales rise to $4.56 bln vs $4.33 bln 8:00 a.m. April 25, 2014 - Ben Eisen
AbbVie Q1 EPS edges up to $0.61; Adjusted: $0.71 8:00 a.m. April 25, 2014 - Ben Eisen
AbbVie Q1 profit rises to $980 mln vs $968 mln 8:00 a.m. April 25, 2014 - Ben Eisen
I have no qualms about taking Gilead’s $84,000 drug 7:30 a.m. April 22, 2014 - Tim Mullaney
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Abbott Labs profit falls 31% 8:45 a.m. April 16, 2014 - MarketWatch.com
First Solar tops S&P 500; Alcoa up ahead of earnings 3:52 p.m. April 8, 2014 - Sue Chang
Gilead: Hepatitis C Japan trial meets endpoint 3:44 a.m. April 3, 2014 - MarketWatch.com
Investors may need to go long if they hope to reap Baxter spinoff rewards 11:40 a.m. March 27, 2014 - Russ Britt
Jobs, winter weather to test record stock levels 7:02 a.m. March 2, 2014 - Wallace Witkowski
Analyst upgrades Gilead, says biotech is 'too good not to own' 3:06 p.m. Feb. 4, 2014 - Russ Britt
More positive tests for hep C drug boost AbbVie and Enanta shares 11:52 a.m. Jan. 31, 2014 - Russ Britt
Stock investors trash market darlings, face Apple, Fed 9:01 a.m. Jan. 26, 2014 - Wallace Witkowski
Mounting optimism for hepatitis C drug boosts Gilead to lead S&P 500 4:09 p.m. Jan. 16, 2014 - Russ Britt
Investors warm up to Gilead's test results; shares climb 5% by close 5:49 p.m. Dec. 18, 2013 - Russ Britt

April Aristocrat Dogs 7% - 9% Upsides Led By Consumer Goods And Services 12:45 p.m. May 8, 2014 - Seeking Alpha
Abbvie submits marketing app to EMA 7:36 a.m. May 8, 2014 - Seeking Alpha
3 Stocks Raising The Drugs Industry Higher 1:02 p.m. May 7, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ABBV WCG CFN FMS 8:45 a.m. May 7, 2014 - InvestorPlace.com
UPDATE: Morgan Stanley Upgrades AbbVie 7:46 a.m. May 7, 2014 - benzinga.com
Top Analyst Upgrades and Downgrades: eBay, GNC, Groupon, Hecla, J.C. Penney, Whole Foods and More 7:27 a.m. May 7, 2014 - 247WallSt.com
Enanta Pharmaceuticals: A Potential Play On Drug-Resistant Bacteria 4:16 p.m. May 6, 2014 - Seeking Alpha
Gilead Is Set To Grow 11:09 a.m. May 5, 2014 - Seeking Alpha
Why Target Shares Fell Rather Than Rose on CEO Firing 10:27 a.m. May 5, 2014 - 247WallSt.com
Finding Yield In Health Care 2:32 a.m. May 5, 2014 - Seeking Alpha
Two Big Pharma Picks to Buy Now 2:25 a.m. May 3, 2014 - Barrons.com
Medical Devices Face Onslaught Of Pricing Pressure 4:26 p.m. May 2, 2014 - Investors Business Daily
10 Healthcare Dogs Script 9% To 19% April Upsides 10:22 a.m. May 2, 2014 - Seeking Alpha
5 Weird & Unloved ETFs Getting The Job Done 7:05 a.m. May 2, 2014 - InvestorPlace.com
5 Biotech Stocks Ready To Resume Their Rally 5:08 p.m. May 1, 2014 - Barrons.com
MedTech's Partial Tax Repeal: Is It Enough? - Zacks Analyst Interviews 5:03 a.m. May 1, 2014 - Zacks.com
MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook 5:03 a.m. May 1, 2014 - Zacks.com
Repros Has an Edge on Auxilium 3:02 p.m. April 30, 2014 - Barrons.com
Momenta Pharmaceuticals Has Value In The Sum Of The Drugs 10:35 a.m. April 29, 2014 - Seeking Alpha
Stock Market News for April 29, 2014 - Market News 10:06 a.m. April 29, 2014 - Zacks.com

AbbVie Submits for EU Marketing Authorization its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Chronic Hepatitis C 2:00 a.m. May 8, 2014 - PR Newswire - PRF
Financial Results, Study Results, and Conference Schedules - Analyst Notes on Actavis, BMS, Baxter, Biogen Idec and AbbVie 9:00 a.m. May 6, 2014 - PR Newswire - PRF
Approvals from the European Commission and Release of Quarterly Financial Results - Analyst Notes on Merck, Johnson & Johnson, Bristol-Myers Squibb, Teva and AbbVie 8:00 a.m. May 2, 2014 - PR Newswire - PRF
Active Equities Technical Coverage -- Research on Mondelez Intl., Time Warner, AbbVie, and FireEye 4:40 a.m. May 1, 2014 - PR Newswire - PRF
Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014 3:10 p.m. April 28, 2014 - PR Newswire - PRF
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard 8:00 a.m. April 28, 2014 - PR Newswire - PRF
AbbVie Reports First-Quarter 2014 Financial Results 7:54 a.m. April 25, 2014 - PR Newswire - PRF
Stocks Close to Announcing their Earnings -- Research on AbbVie, Weyerhaeuser, Tyco Intl., and Colgate-Palmolive 5:11 a.m. April 25, 2014 - PR Newswire - PRF
Quarterly Results, FDA Approvals, Intellectual Property Appeals, New Drug Applications, and Initiated Clinical Trials - Analyst Notes on Johnson & Johnson, Merck, Teva, Bristol-Myers Squibb and AbbVie 8:00 a.m. April 24, 2014 - PR Newswire - PRF
AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C 8:46 a.m. April 22, 2014 - PR Newswire - PRF
Application Now Open for Students with Cystic Fibrosis for the 2014 AbbVie CF Scholarship 11:00 a.m. April 16, 2014 - PR Newswire - PRF
AbbVie Announces Initiation of Pivotal Phase III Study of Veliparib (ABT-888) for Patients with Non-Small Cell Lung Cancer 8:00 a.m. April 15, 2014 - PR Newswire - PRF
AbbVie to Present Late-Breaking Results from TURQUOISE-II Study in Chronic Hepatitis C Patients with Cirrhosis at the 2014 International Liver Congress™ 1:00 a.m. April 12, 2014 - PR Newswire - PRF
Equities to Watch in the Health Care Sector -- Research on AbbVie, GlaxoSmithKline, AstraZeneca, and Novartis 9:46 a.m. April 9, 2014 - PR Newswire - PRF
AbbVie to Host First-Quarter Earnings Conference Call 8:00 a.m. April 7, 2014 - PR Newswire - PRF
Financial Results, Launches, Adjusted Conversion Rates, Upcoming Presentations, and Stock Movements - Analyst Notes on AbbVie, Chemed, Antares Pharma, Magellan Health Services, and Natus Medical 8:00 a.m. April 3, 2014 - PR Newswire - PRF
AbbVie to Present Detailed Results from Phase III Studies in Patients with Chronic Hepatitis C at the 2014 International Liver Congress™ 5:00 a.m. March 24, 2014 - PR Newswire - PRF
Health Care Sector Equities Technical Commentary -- Research on AbbVie, GlaxoSmithKline, AstraZeneca and Novartis 6:44 p.m. March 21, 2014 - PR Newswire - PRF
AbbVie Initiates New Clinical Trial to Evaluate HUMIRA® (adalimumab) for the Treatment of Fingernail Psoriasis in Patients with Moderate to Severe Chronic Plaque Psoriasis 7:00 a.m. March 20, 2014 - PR Newswire - PRF
Investment Grants, Data Presentations, Clinical Study Results, and Collaborative Programs - Analyst Notes on UnitedHealth Group, Bristol-Myers Squibb, AbbVie, Cigna, and OXiGENE 8:00 a.m. March 14, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sotheby's to Auction Largest Flawless Paraiba Tourmalines

Jaw-Dropping Gemstones Poised for Auction Glory The art of gemology isn't just about shiny rocks; it's a concoction of beauty, rarity, and, most importantly, value. And when the world's finest stones hit the auction block, it's akin to an epic performance in a long-awaited drama. On September 17, 2026, these precious Paraiba Tourmalines, fashioned by the adept hands of...

MMRO Achieves URAC AI Accreditation, Ensures Compliance

A Milestone in Healthcare AI: MMRO's New Accreditation When AI in healthcare gets an official nod from the big guys like URAC, it's a significant moment. We're talking about Managed Medical Review Organization, Inc. (MMRO), a firm that's just earned the URAC Artificial Intelligence in Health Care Accreditation. Now, this isn't just some rubber stamp; it's a testament to...

ACEMAGIC Unveils New AI Mini Workstation at IFA 2026

A Glimpse Into ACEMAGIC's Latest Innovation Look if you had told me five years ago that AI mini workstations would be making waves, I'd have probably smirked. Yet, here we are; ACEMAGIC is setting the stage at IFA 2026 in Berlin with their fresh-out-the-oven F9A AI mini workstation, powered by AMD's Ryzen AI Max+ PRO 495 processor. It all goes down from September 4 to 8...

MINISFORUM Strikes with New AI Powerhouses at IFA

MINISFORUM's Bold Move in Edge AI Computing There's no doubt that 2026 is about AI making its way to the forefront, and MINISFORUM is moving full steam ahead. Introduced at the IFA in Berlin, MINISFORUM unveiled its latest input into the edge AI scene with the AMD Ryzen AI MAX+ PRO 495 driving the charge. Now, these aren't just ordinary upgrades, mind you. We're talking...

Beko's Innovations in Appliances: Practical Gains Measured

Finding Efficiency in Everyday Routines Let’s kick things off with a no-nonsense look at Beko's thrust into the heart of day-to-day living. This isn’t about bells and whistles, folks—it's about delivering real, quantifiable improvements in how appliances serve us at home. Istanbul's latest reveal is a nod to practicality. From the onset, Beko wraps its hands around...

ASU Teams Up for National Manufacturing Workforce Push

ASU's Role in Reviving American Manufacturing The Foundry School is a big hit for Arizona State University (ASU) as it joins hands with seven other top-tier universities under the U.S. Departments of State and Labor's initiative. This project is all about sculpting the future players of American manufacturing. In a scene highlighted by the Vice President and girded by...

What to Expect from KeyCorp at Barclays Event

KeyCorp's Next Move: An Insider's View Yep, circle that calendar, folks. Looks like KeyCorp's gonna be laying it all out there for the financial world to see. Clark Khayat, their numero uno money guy, is hitting the stage at the Barclays Global Financial Services Conference on Sept. 14. So grab the popcorn—or, more like, your portfolio tracker—because this could get...

Innovative SOV Launches for Offshore Wind Revolution

A New Era for Offshore Wind Operations Mark my words, folks, this launch ain't just some minor milestone swaying gently on the industry seas. ZPMC's 'Wind of Ocean' is about to kickstart a whole new game in Europe's offshore wind space. Built with brains and brawn, this vessel embodies the future of sustainable and efficient offshore operations. The announcement from...

Charity's Bold Move: Acquiring Wayfinder for K-12 Impact

Public Charity Expands Into Education Well, here's something that's bound to turn a few heads: a fast-growing public charity has just made its first acquisition in the K-12 sphere by snapping up Wayfinder. The stakes are getting interesting. When a charity starts playing in the acquisition space, you're looking at a change in strategy that deserves close attention. Why...

JIMMY's Nespure N9: Innovating Coffee and Clean Water

Unpacking JIMMY's Latest Innovation at IFA Every now and then, something comes along that makes you think, "Why didn't I think of that?" Well, JIMMY just hit that nail square on the head with its latest concoction—the Nespure N9. Debuting at the IFA 2026 in Berlin, this little gizmo combines water purification with coffee brewing, all from a modestly-sized countertop...